Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

The Alopecia Areata Investigator’s Global Assessment (AA‐IGA™) Scale: A Measure for Evaluating Clinically Meaningful Success in Clinical Trials

(2020) K.W. Wyrwich et al.   BRITISH JOURNAL OF DERMATOLOGY

Development of the Scalp Hair Assessment PRO™ measure for alopecia areata

(2020) K.W. Wyrwich et al.   BRITISH JOURNAL OF DERMATOLOGY

Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata

(2020) Kathleen W. Wyrwich et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Epidemiology of alopecia areata, ophiasis, totalis and universalis: A systematic review and meta-analysis

(2019) Harrison H. Lee et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

(2018) A. Jabbari et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Alopecia areata is associated with impaired health-related quality of life: a survey of affected adults and children, and their families

(2018) Lucy Y. Liu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Alopecia areata is a medical disease

(2018) Dorota Z. Korta et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Alopecia areata

(2018) Lauren C. Strazzulla et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Alopecia areata: A multifactorial autoimmune condition

(2018) Teontor Simakou et al.   JOURNAL OF AUTOIMMUNITY

Tofacitinib for the treatment of alopecia areata and variants in adolescents

(2017) Brittany G. Craiglow et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Alopecia areata

(2017) C. Herbert Pratt et al.   Nature Reviews Disease Primers

Alopecia areata and health-related quality of life: a systematic review and meta-analysis

(2016) F. Rencz et al.   BRITISH JOURNAL OF DERMATOLOGY

Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review

(2016) Lucy Y. Liu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The autoimmune basis of alopecia areata: A comprehensive review

(2015) Naseeha Islam et al.   AUTOIMMUNITY REVIEWS

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

(2015) Ali Jabbari et al.   EBioMedicine

Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis

(2014) Brittany G. Craiglow et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition

(2014) Luzhou Xing et al.   NATURE MEDICINE